Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside
Radiolabeled peptides can deliver radiation selectively to tumors via targeting peptide receptors that are overexpressed on the surface of cancer cells. The radiation is used either for detection (imaging) or for destruction (therapy) of these tumors. The Division of Radiopharmaceutical Chemistry at...
Main Authors: | Rosalba Mansi, Melpomene Fani |
---|---|
Format: | Article |
Language: | deu |
Published: |
Swiss Chemical Society
2021-06-01
|
Series: | CHIMIA |
Subjects: | |
Online Access: | https://www.ingentaconnect.com/contentone/scs/chimia/2021/00000075/00000006/art00007 |
Similar Items
-
Radiooznačeni peptidi v nuklearni medicini
by: Marko Krošelj, et al.
Published: (2018-10-01) -
Targeted Radiotherapeutics from 'Bench-to-Bedside'
by: Cristina Müller, et al.
Published: (2020-12-01) -
Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
by: Melpomeni Fani, et al.
Published: (2017-03-01) -
[68Ga]Exendin-4: Bench-to-Bedside : PET molecular imaging of the GLP-1 receptor for diabetes and cancer
by: Selvaraju, Ram kumar
Published: (2015) -
Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications
by: Meike eKörner, et al.
Published: (2012-12-01)